LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
BT-20 LDN-193189
3.33
uM
LJP5
 0.2820 0.0949 -0.0800 0.1962
BT-20 LDN-193189
10
uM
LJP5
 0.0934 0.0212 -0.5070 0.0475
BT-20 PF431396
0.04
uM
LJP5
 0.9192 0.0192 0.9022 0.0247
BT-20 PF431396
0.12
uM
LJP5
 0.8053 0.0172 0.7625 0.0205
BT-20 PF431396
0.37
uM
LJP5
 0.5534 0.0521 0.4144 0.0697
BT-20 PF431396
1.11
uM
LJP5
 0.3723 0.0288 0.1213 0.0663
BT-20 PF431396
3.33
uM
LJP5
 0.3265 0.0236 0.0389 0.0706
BT-20 PF431396
10
uM
LJP5
 0.2166 0.0478 -0.1897 0.1242
BT-20 Celastrol
0.04
uM
LJP6
 1.0633 0.0191 1.0735 0.0207
BT-20 Celastrol
0.12
uM
LJP6
 1.0765 0.0201 1.0894 0.0218
BT-20 Celastrol
0.37
uM
LJP6
 0.8913 0.0240 0.8674 0.0270
BT-20 Celastrol
1.11
uM
LJP6
 0.4949 0.1754 0.2778 0.2682
BT-20 Celastrol
3.33
uM
LJP6
 0.1939 0.0497 -0.2653 0.0870
BT-20 Celastrol
10
uM
LJP6
 0.1337 0.0223 -0.4082 0.0548
BT-20 SU11274
0.04
uM
LJP5
 1.0537 0.0193 1.0616 0.0214
BT-20 SU11274
0.12
uM
LJP5
 1.0376 0.0068 1.0442 0.0099
BT-20 SU11274
0.37
uM
LJP5
 1.0028 0.0145 1.0035 0.0168
BT-20 SU11274
1.11
uM
LJP5
 0.9338 0.0076 0.9217 0.0084
BT-20 SU11274
3.33
uM
LJP5
 0.8492 0.0059 0.8186 0.0066
BT-20 SU11274
10
uM
LJP5
 0.3401 0.0174 0.0654 0.0476
BT-20 Canertinib
0.04
uM
LJP6
 0.9163 0.0180 0.8956 0.0254
BT-20 Canertinib
0.12
uM
LJP6
 0.9024 0.0058 0.8804 0.0042
BT-20 Canertinib
0.37
uM
LJP6
 0.8628 0.0165 0.8312 0.0158
BT-20 Canertinib
1.11
uM
LJP6
 0.8494 0.0242 0.8141 0.0257
BT-20 Canertinib
3.33
uM
LJP6
 0.7695 0.0329 0.7099 0.0351